RecallRadar

FDA Drug recall D-0161-2016

Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017,…

On 2015-11-04 the FDA classified a Class II recall of Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017,… by Pfizer, citing subpotent Drug.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0161-2016
ClassificationClass II
Statusterminated
Initiated2015-09-24
Published2015-11-04
Last updated2026-09-13 11:51 UTC
CompanyPfizer
DistributionUS

Product

Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017, NDC 0009-0029-01

Reason

Subpotent Drug

Identifiers

ndc0009-0029-01
ndc0009-0029-46
ndc0009-0029-02
ndc0009-0029-14
ndc0009-0055-01
ndc0009-0055-46
ndc0009-0055-03
ndc0009-0055-15
ndc0009-0090-01
ndc0009-0090-04
ndc0009-0090-13
ndc0009-0094-01
ndc0009-0094-03
code_infoLot # C111054; Exp. 02/16

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0161-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.